Le-Ning Zhang Selected Research

1- (1- nicotinoylpiperidin- 4- yl)- 3- (4- (trifluoromethoxy)phenyl)urea

3/2011

Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Le-Ning Zhang Research Topics

Disease

4	Atherosclerosis 05/2010 - 01/2008
4	Hyperplasia 03/2008 - 04/2006
3	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2015
3	Vascular Remodeling 09/2009 - 07/2007
2	Neoplasms (Cancer) 01/2019 - 01/2015
2	Hypertension (High Blood Pressure) 03/2011 - 02/2011
2	Obesity 03/2011 - 02/2011
2	Abdominal Aortic Aneurysm 09/2009 - 03/2008
2	Vascular Diseases (Vascular Disease) 01/2008 - 07/2007
1	Osteosarcoma (Osteogenic Sarcoma) 12/2019
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Paraganglioma (Paragangliomas) 07/2019
1	Lymphatic Metastasis 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Gastroesophageal Reflux (GERD) 01/2018
1	Esophageal Neoplasms (Esophageal Cancer) 01/2015
1	Insulin Resistance 02/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2010
1	Aneurysm (Aneurysms) 05/2010
1	Inflammation (Inflammations) 05/2010
1	Dyslipidemias (Dyslipidemia) 09/2009
1	Hyperlipidemias (Hyperlipidemia) 01/2008
1	Experimental Arthritis 01/2007
1	Rheumatoid Arthritis 01/2007
1	Vascular System Injuries 04/2006

Drug/Important Bio-Agent (IBA)

5	Angiotensin IIIBA 03/2011 - 07/2007
4	Epoxide HydrolasesIBA 03/2011 - 09/2009
3	Therapeutic UsesIBA 12/2019 - 01/2007
3	ApolipoproteinsIBA 05/2010 - 03/2008
2	Biological ProductsIBA 12/2019 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2015
2	1- (1- acetyl- piperidine- 4- yl)- 3- adamantan- 1- yl- ureaIBA 03/2011 - 02/2011
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	CatecholaminesIBA 07/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	prolinedithiocarbamate (PDTC)IBA 01/2018
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2015
1	Cyclin A1IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2011
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2011
1	1- (1- nicotinoylpiperidin- 4- yl)- 3- (4- (trifluoromethoxy)phenyl)ureaIBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 02/2011
1	EicosanoidsIBA 05/2010
1	AcidsIBA 05/2010
1	Interferon-betaIBA 03/2008
1	Apolipoproteins E (ApoE)IBA 03/2008
1	Peptide Hydrolases (Proteases)FDA Link 01/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2007
1	Chemokine CCL3IBA 07/2007
1	Chemokine CXCL12IBA 04/2006

Therapy/Procedure

4	Ligation 09/2009 - 07/2007
2	Therapeutics 01/2019 - 05/2010
1	Drug Therapy (Chemotherapy) 12/2019
1	Radiotherapy 12/2019